Study of KC1086 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called KC1086 for people whose cancer has spread or come back and who have already tried other treatments. It may help if standard treatments are no longer working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced or metastatic cancer that has been confirmed by a biopsy.
- Your cancer has not responded to or you cannot tolerate standard treatments.
- You have at least one tumor that can be measured or seen on scans.
- You are generally able to take care of yourself (performance status 0 or 1).
- Your doctors expect you to live more than 12 weeks.
- Your bone marrow, kidney, and liver function are adequate.
- You have not had certain brain metastases, other cancers recently, or serious infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 trial studies how a new medicine (KC1036) works and how safe it is for people with advanced solid cancers that have grown despite standard treatments. It may help future patients by showing whether the drug can control cancer in difficult-to-treat cases.
This early-phase study tests whether KC1036 can treat advanced digestive system cancers that have come back or spread after standard treatment. It may help people by shrinking tumors or slowing growth, and it will also check safety and side effects.
This trial tests KC1036 in people with advanced thymoma or thymic carcinoma whose cancer came back or spread after their first standard chemotherapy. It may offer a new treatment option when earlier treatment no longer worked.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This trial tests a new drug called GI-108, which is designed to help your immune system fight cancer. It is for people with advanced or metastatic solid tumors that have not responded to other treatments.
This trial tests an experimental drug called KM602 for people with advanced solid tumors that have stopped responding to standard treatments, particularly melanoma and non-small cell lung cancer. It aims to see if the drug is safe and effective in shrinking or controlling tumors.
Hear when a new Advanced Solid Tumors Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.